February is American Heart Month, so I felt it was finally time to share my personal heart story. My paternal line has a long ...

Corewell Health was awarded the Mitral Valve Repair Reference Center Award, one of only 24 centers in the country.

High-volume centres achieve excellent long-term survival and low reoperation rates in mitral valve repair—key findings ...

The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of ...

Since Cosgrove and Sabik first described minimally invasive aortic valve surgery in 1996, [74] there has been a significant expansion in popularity, experience and techniques associated with ...

Transcatheter Aortic Valve Replacement (TAVR) global sales grew 5.3% year-over-year to $1.04 billion in the fourth quarter. Transcatheter Mitral and Tricuspid Therapies (TMTT) sales reached We ...

The rising trend in health and lifestyle related problems in the world warrants us to be well informed and health-conscious of the latest happenings in this field. Medindia offers a freely ...

ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.

When considering the application of emerging technologies for the treatment of significant MR, it is anticipated that these will be used among patients with advanced comorbidities, deemed unsuitable ...